Aligos Therapeutics, Inc. Deferred Offering Costs
Discontinued › Balance Sheet › Assets
us-gaap:DeferredOfferingCosts · last filed 2021-03-23
- 2020-12-31: Deferred Offering Costs $0.00.
- 2020-09-30: Deferred Offering Costs $2.61M.
- 2019-12-31: Deferred Offering Costs $0.00.
| Period end | Deferred Offering Costs |
|---|---|
| 2020-12-31 | $0.00 10-K · filed 2021-03-23 |
| 2020-09-30 | $2.61M 10-Q · filed 2020-11-25 |
| 2019-12-31 | $0.00 10-K · filed 2021-03-23 |